Drugs affecting the ● Support group for epileptics
1. CNS ● Report adverse effects – report to the doctor
2. Respiratory 3. Cardiovascular Cardiovascular 4. GIT 1. Anti-hypertensive 5. Endocrine 2. Cardiac Glycosides 3. Anti-anginal drugs 4. Anti-arrhythmic drugs CNS Depressants Common Drugs: Angiotensin antagonist (Angiotensin converting enzyme inhibitor or ACEI) Sedative-hypnotics - Common Drugs: ● PRILS Benzodiazepine – action – increase GABA – calming ● enalapril effect ● lisinopril Anesthetics ● captopril Analgesics Anticonvulsants Angiotensin II receptor blockers Anxiolytics - Increase in 3Ds - drowsiness, dizziness, ● The “sartans” and decrease in BP ● Losartan ● Valsartan Antidepressants – TCA, MAOI, SSRI ● newest group, may only be indicated when ACEI Analgesic - drugs that relieve the sensation of pain are intolerable, mostly free of side effects but ● Non-narcotic analgesics very costly. ○ Salicylates – aspirin (analgesic, ● Decrease blood pressure. antipyretic, anti-inflammatory, decreases platelet aggregation) Beta blockers - block the effects of ○ NSAID – meloxicam (analgesic, anti- epinephrine/adrenaline. inflammatory) Reduces sympathetic stimulation in cardiac muscle. ○ Para aminophenol – acetaminophen Causing the heart to beat more slowly and with less (analgesic) force, which lowers blood pressure. ● Narcotic analgesics Beta blockers also help open veins and arteries to improve blood flow. Increase blood flow to the kidney. Nursing Implications -Assess respiratory status – Naloxone (Narcan) for opiod Calcium Channel Blockers toxicity ● They work by slowing the movement -Assess for hypotension of calcium into the cells of the heart and blood -Monitor bowel elimination vessel walls, which makes it easier for the heart -Evaluate pain response to medication to pump and widens blood vessels. ● Examples of calcium channel blockers Antidepressant include: ● TCA – tricyclic antidepressants - increases ● Amlodipine (Norvasc) neurotransmitter concentration levels of NE and ● Diltiazem (Cardizem, Tiazac, others) serotonin. ● Nicardipine. ● - Anticholinergic effect ● Nifedipine (Adalat CC, Procardia) ● MAOI – mono amine oxidase inhibitors – inhibit MAO enzyme that metabolizes NE and Cardiac Glycosides serotonin ● digoxin (Lanoxin) ● - Hypertensive crisis – avoid eating tyramine rich ● digitoxin (Crystodigin) foods like dairy products Effects: ● SSRI – Serotonin Reuptake Inhibitors - inhibit ● positive inotropic effect – increase force of the serotonin uptake. contraction ● - administer with meals to reduce nausea. ● Negative chronotropic effect - decrease heart rate Anti-convulsant - substance that prevents, reduces, ● Adverse reactions: digitalis toxicity – or stops the severity of epileptic or other convulsive heart/pulse rate less than 60. disorders. ● Therapeutic level is 0.5 to 2.0 nanograms/mL) ● Antidote: digoxin immune fab (Digibind) Nursing Consideration ● CNS: dizziness ● Eat food with drug – causes gastric irritation ● Antacids decrease – it will delay the absorption of anti-epileptic drugs Antianginal Drugs Anti-emetic drug – prevent vomiting ● Nitrates – relaxes vascular smooth ● Antihistamine - meclizine muscles, decrease arterial BP, decrease ● Anticholinergics – scopolamine, transderm left ventricle workload. VASODILATION scoop (applied behind the ear) ● Beta-blockers – DECREASE HEART ● Dopamine antagonists - metoclopramide RATE ● Serotonin receptor antagonists - ondansetron ● Calcium-channel blockers – Anti diarrheal drug DECREASE FORCE OF CONTRACTION
● E.g., nitroglycerine (Nitrostat, Transderm Nitro) Loperamide - direct muscles of the GI tract to slow ● Usually given sublingually - activity and allow increased time for absorption of fluid ● Used to terminate acute attack of angina and electrolytes. ● If chest pain persists for more than 5 minutes, Laxatives hospital consultation should be done Bulk forming immediately. ▪ natural fibrous, non-absorbable substances Action: fluid in the intestinal contents →enlarges bulk → GIT stimulates local stretch receptors→ GI motility Common drugs: methycellulose (Cologel) Peptic Ulcers psyllium (Metamucil) ● Acid-suppressing drugs dietary fiber (Fibrosine) ● Antacids lactulose (Duphalac) ● H2 receptor antagonists ● Proton-pump inhibitors Respiratory ● Mucosal protective agents ● Upper Respiratory Agents ● Sucralfate ● Antihistamine ● Prostaglandin analogue ● Decongestants ● Bismuth-containing compounds ● Expectorants ● Antacids – neutralize secreted acid. ● Antitussives Side effect: rebound acidity: stomach produces more ● Lower Respiratory acid in response to an alkaline environment ● Bronchodilators ● H2 receptor antagonist - selectively block ● Anti-inflammatory specific histamine receptor sites leading to a reduction in gastric acid secretion. Antihistamine – blocks H1 receptors thereby ● Cimetidine (Tagamet) – side effect: androgenic decreasing allergic response. antagonist ● Allergic responses like itchy, watery ● Proton-pump inhibitors - inhibit the hydrogen- eyes, rhinitis. potassium-ATPase enzyme system located in ● Benadryl AH, Dimetapp the gastric parietal cells. ● Mucosal protective agents Decongestants – eliminate or reduce congestion or ● Sucralfate (Carafate) Protect the lining of the swelling. gastrointestinal tract from ● Common drugs – pseudoephedrine, harmful stomach acid. phenylephrine ● Nursing considerations: ● limit 5-7 days to prevent rebound nasal ● Evaluate the effectiveness of the medications if congestion. the client states relief from abdominal pain caused by hyperacidity. Expectorant – liquefy secretions by enhancing the ● Side effects of antacids: output of respiratory fluid reducing the viscosity of ● rebound acidity: stomach produces more acid in secretions and decreasing its adhesiveness. response to an alkaline environment ● Guafenesin – loosen bronchial ● constipation: if aluminum products are used secretions for effective coughing. ● diarrhea: if magnesium product used ● Benadryl, Robitussin ● fluid retention if sodium bicarbonate products ● Increase water intake. are used ● milk-alkali syndrome (alkalosis, renal calcium Antitussives – supress the cough reflex. Non- deposits, severe electrolyte disorders): if calcium productive cough. salts are used ● dextromethorphan (Robitussin DM) ● reduce the frequency of cough. Lower Respiratory Tract disorder Alpha-glucosidase inhibitors Common disorder: MOA: inhibits the digestive enzyme (alpha-glucosidase) ● Bronchial asthma - Reversible airway in the small intestine (responsible for the release of obstruction that is characterized by glucose from the complex carbohydrates (CHO) in the hyperirritability and inflammation of the airways. diet) → CHO cannot be absorbed → CHO passed into Main problems – bronchoconstriction and the large intestine. inflammation It stimulates the pancreas to produce insulin and Medications: Bronchodilators increases peripheral receptors sensitivity to insulin ● 1. Sympathomimetic decreasing serum glucose levels. ● 2. Xanthine derivatives – methylxanthines – Aminophylline-Theophylline 3. Biguanides Side effects: Cardiac stimulation: ● Drugs: phenformin, metformin (Humamet, tachyarrhythmias, tachycardia Glucophage, Avandamet, Glucovance) 4. Thiazolidinediones ● 3. Anticholinergics (parasympatholytic) ● Used for decreased insulin-stimulated glucose Medication: Anti inflammatory uptake ● 1. Glucocorticoids - decreasing the inflammatory ● Improve the response of muscle and adipose response and reduce mucus plugs and edema tissue to insulin in patients who are otherwise secondary to vascular permeability. relatively unresponsive, notably the extremely ● 2. Leukotriene receptor antagonist – Zafirlukast, obese Montelukast ● Decrease insulin resistance Nursing considerations: Drugs: ● assess respiratory status ● Rosiglitazone (Avandia, ● assess liver function tests Avandament) ● medication does not treat acute asthma attacks ● piolitazone (Actos) ● Best suited for patient who are obese or insulin-resistant Endocrine ● Anti-Diabetic Drugs 5. Meglitinides Insulin - increases glucose transport into cells and ● Drugs: Repaglinide (NovoNorm) Nate glinide promotes conversion of glucose to glycogen decreasing (Starlix) serum glucose levels ● Stimulate the beta cells to release insulin ● Should not be prescribed for client with liver dysfunction ● May cause hypoglycemic reaction ● Best suited for patients with recently diagnosed type diabetes who have high postprandial glucose levels
Normal glucose level - 4.2 – 6.4 mmol/L (75 – 115
mg/dL)
Oral Hypoglycemic Agents – OHA
Sulfonylureas MOA: stimulates the beta cells secrete more insulin → insulin cell receptors → inc. ability of cells to bind insulin for glucose metabolism